Suven Life Sciences informs about outcome of board meeting

05 Jun 2020 Evaluate

Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Suven Life Sciences has informed that the Board of Directors of the company at its meeting held today June 5, 2020, has taken on record and approved the Audited Standalone and Consolidated Financial Results of the Company under Ind AS for the quarter and for the year ended 31st March, 2020 and approved the various matters as enclosed. The board meeting commenced at 11.30 am and concluded at 13.45 pm.

The above information is a part of company’s filings submitted to BSE.


 

Suven Life Sciences Share Price

171.95 -5.40 (-3.04%)
16-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1782.80
Dr. Reddys Lab 1279.00
Cipla 1500.00
Zydus Lifesciences 913.90
Lupin 2089.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×